Bruce Peacock - Net Worth and Insider Trading

Bruce Peacock Net Worth

The estimated net worth of Bruce Peacock is at least $6 dollars as of 2024-11-13. Bruce Peacock is the Director of Windtree Therapeutics Inc and owns about 10 shares of Windtree Therapeutics Inc (WINT) stock worth over $6. Details can be seen in Bruce Peacock's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruce Peacock has not made any transactions after 2020-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bruce Peacock

To

Bruce Peacock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bruce Peacock owns 8 companies in total, including Ocular Therapeutix Inc (OCUL) , Windtree Therapeutics Inc (WINT) , and Dicerna Pharmaceuticals Inc (DRNA) among others .

Click here to see the complete history of Bruce Peacock’s form 4 insider trades.

Insider Ownership Summary of Bruce Peacock

Ticker Comapny Transaction Date Type of Owner
OCUL Ocular Therapeutix Inc 2016-06-02 director
WINT Windtree Therapeutics Inc 2020-05-22 director
DRNA Dicerna Pharmaceuticals Inc 2017-07-18 director
LIMIT LIMIT 2015-11-19 director
LIMIT LIMIT 2014-01-02 CFO & CBO
LIMIT LIMIT 2011-10-06 director
LIMIT LIMIT 2009-05-28 director
LIMIT LIMIT 2008-12-23 director

Bruce Peacock Latest Holdings Summary

Bruce Peacock currently owns a total of 1 stock. Bruce Peacock owns 10 shares of Windtree Therapeutics Inc (WINT) as of May 22, 2020, with a value of $6.

Latest Holdings of Bruce Peacock

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WINT Windtree Therapeutics Inc 2020-05-22 10 0.56 6

Holding Weightings of Bruce Peacock


Bruce Peacock Form 4 Trading Tracker

According to the SEC Form 4 filings, Bruce Peacock has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 4 shares on May 22, 2020, which cost Bruce Peacock around $25,375.

Insider Trading History of Bruce Peacock

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bruce Peacock Trading Performance

GuruFocus tracks the stock performance after each of Bruce Peacock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Peacock is 5.77%. GuruFocus also compares Bruce Peacock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Peacock within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bruce Peacock's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bruce Peacock

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -15.11 LIMIT LIMIT LIMIT LIMIT LIMIT

Bruce Peacock Ownership Network

Ownership Network List of Bruce Peacock

No Data

Ownership Network Relation of Bruce Peacock

Insider Network Chart

Bruce Peacock Owned Company Details

What does Ocular Therapeutix Inc do?

Who are the key executives at Ocular Therapeutix Inc?

Bruce Peacock is the director of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .

Ocular Therapeutix Inc (OCUL) Insider Trades Summary

Over the past 18 months, Bruce Peacock made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .

In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocular Therapeutix Inc Insider Transactions

No Available Data

Bruce Peacock Mailing Address

Above is the net worth, insider trading, and ownership report for Bruce Peacock. Currently GuruFocus does not have mailing address information for Bruce Peacock.